Search
Searching with a thematic focus on Health, HIV and AIDS, ARVs, HIV and AIDS treatment and care
Showing 31-40 of 43 results
Pages
- Document
Drugs in development: new promise [ACRIA Update, vol 12]
AIDS Community Research Initiative of America, 2003This issue of ACRIA Update focuses on antiretrovirals that are being developed to deal with problems of new formulations of old drugs, second generation drugs in existing classes, drugs like entry inhibitors that target HIV at different points in its life cycle, and drugs that are in very early stages of development.The paper demonstrates that we may never hear of some of these drugs again; theDocumentThe cost of treating HIV/AIDS with ARVs in South Africa: Who knows? Who cares?
International AIDS Economics Network, 2002This paper reports on a survey conducted of completed studies and research in progress produced by public, private and non-government institutions that have estimated and documented the cost of treatment of HIV/AIDS with ARVs in South Africa.DocumentDemystifying antiretroviral therapy in resource-poor settings
Access to Essential Medicines Campaign, MSF, 2003This paper uses the example of a poor township 30 kilometres outside Cape Town to find out if antiretroviral therapy is possible in severely resource-constrained environments and to discover the best ways to deliver these drugs.Zidovudine (AZT), first became available in Khayelitsha township’s two maternity wards in early 1999, and the programme has subsequently become one of the continent’s biDocumentFood and nutrition implications of antiretroviral therapy in resource limited settings
Food and Nutrition Technical Assistance Project, 2004This technical note from the Food and Nutrition Technical Assistance (FANTA) Project provides information and guidance about the food and nutrition implications of antiretroviral therapy (ART) in resource limited settings.DocumentAccelerating action against AIDS in Africa
Joint United Nations Programme on HIV/AIDS, 2003This report, presented at ICASA 2003 in Nairobi, assesses current global commitments to addressing HIV/AIDS. It states that, despite the fact that the pandemic has recently reached the top of the African and international agenda, resources are still nowhere near sufficient.DocumentTRIPS, drug patents and access to medicines: balancing incentives for R&D with public health concerns
Knowledge Economy Node, Development Gateway, 2003This interview with Professor Kieth Maskus looks into the impacts of the agreed deal on implementing the Doha declaration on TRIPs and public health.The questioning focuses on the likely impacts of the agreement on pharmaceutical companies, generic producers and developing countries but also looks into some of the likely interpretation of the wording of the agreement.Key points are:EDocumentAIDS, public policy and child well-being
UNICEF Innocenti Research Centre, 2001This paper presents the findings of a global study carried out in 2000 on the specific impact of HIV/AIDS on children.DocumentPrevention of mother-to-child transmission of HIV in Asia: practical guidance for programs
US Agency for International Development, 2002In most countries in Asia, pediatric incidences of HIV/AIDS are increasing.DocumentScaling up anti-retroviral therapy in resource limited settings: treatment guidelines for a public health approach (2003 revision)
World Health Organization WHO File, 2003This document from the World Health Organization (WHO) provides guidance on scaling up antiretroviral therapy (ART) in resource limited settings. It is intended primarily for use by Treatment Advisory Boards, national AIDS programme managers, and other senior level policymakers involved in the planning of national and international HIV care strategies in developing countries.DocumentStigma, HIV/AIDS and prevention of mother-to-child transmission: a pilot study in Zambia, India, Ukraine and Burkina Faso
Panos AIDS Programme, 2001Aims to assess and provide an initial analysis of the extent of perceived and enacted stigma, consider stigma in general and, more specifically, that surrounding mother-to-child transmission, and to explore what steps might be taken to alleviate it.Piolot research was conducted in India (South Asia), Ukraine (Eastern Europe), Burkina Faso (Francophone West Africa) and Zambia (Anglophone SouthPages
